πŸ‡ΊπŸ‡Έ FDA
Patent

US 9382256

Formulation of Syk inhibitors

granted A61KA61K31/5377A61K47/10

Quick answer

US patent 9382256 (Formulation of Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
57
CPC classes
A61K, A61K31/5377, A61K47/10, A61K47/38, A61K9/2027